254 related articles for article (PubMed ID: 29018970)
1. Andersen's syndrome mutants produce a knockdown of inwardly rectifying K
Simkin D; Robin G; Giuliano S; Vukolic A; Moceri P; Guy N; Wagner KD; Lacampagne A; Allard B; Bendahhou S
Cell Tissue Res; 2018 Feb; 371(2):309-323. PubMed ID: 29018970
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms underlying Andersen's syndrome pathology in skeletal muscle are revealed in human myotubes.
Sacconi S; Simkin D; Arrighi N; Chapon F; Larroque MM; Vicart S; Sternberg D; Fontaine B; Barhanin J; Desnuelle C; Bendahhou S
Am J Physiol Cell Physiol; 2009 Oct; 297(4):C876-85. PubMed ID: 19570891
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro functional characterization of Andersen's syndrome mutations.
Bendahhou S; Fournier E; Sternberg D; Bassez G; Furby A; Sereni C; Donaldson MR; Larroque MM; Fontaine B; Barhanin J
J Physiol; 2005 Jun; 565(Pt 3):731-41. PubMed ID: 15831539
[TBL] [Abstract][Full Text] [Related]
4. A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1.
Kokunai Y; Nakata T; Furuta M; Sakata S; Kimura H; Aiba T; Yoshinaga M; Osaki Y; Nakamori M; Itoh H; Sato T; Kubota T; Kadota K; Shindo K; Mochizuki H; Shimizu W; Horie M; Okamura Y; Ohno K; Takahashi MP
Neurology; 2014 Mar; 82(12):1058-64. PubMed ID: 24574546
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid-exacerbated symptoms in an Andersen's syndrome kindred.
Bendahhou S; Fournier E; Gallet S; Ménard D; Larroque MM; Barhanin J
Hum Mol Genet; 2007 Apr; 16(8):900-6. PubMed ID: 17324964
[TBL] [Abstract][Full Text] [Related]
6. Identification and functional characterisation of a novel KCNJ2 mutation, Val302del, causing Andersen-Tawil syndrome.
Ördög B; Hategan L; Kovács M; Seprényi G; Kohajda Z; Nagy I; Hegedűs Z; Környei L; Jost N; Katona M; Szekeres M; Forster T; Papp JG; Varró A; Sepp R
Can J Physiol Pharmacol; 2015 Jul; 93(7):569-75. PubMed ID: 26103554
[TBL] [Abstract][Full Text] [Related]
7. Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome.
Preisig-Müller R; Schlichthörl G; Goerge T; Heinen S; Brüggemann A; Rajan S; Derst C; Veh RW; Daut J
Proc Natl Acad Sci U S A; 2002 May; 99(11):7774-9. PubMed ID: 12032359
[TBL] [Abstract][Full Text] [Related]
8. Impaired interaction between the slide helix and the C-terminus of Kir2.1: a novel mechanism of Andersen syndrome.
Decher N; Renigunta V; Zuzarte M; Soom M; Heinemann SH; Timothy KW; Keating MT; Daut J; Sanguinetti MC; Splawski I
Cardiovasc Res; 2007 Sep; 75(4):748-57. PubMed ID: 17568571
[TBL] [Abstract][Full Text] [Related]
9. Andersen mutations of KCNJ2 suppress the native inward rectifier current IK1 in a dominant-negative fashion.
Lange PS; Er F; Gassanov N; Hoppe UC
Cardiovasc Res; 2003 Aug; 59(2):321-7. PubMed ID: 12909315
[TBL] [Abstract][Full Text] [Related]
10. Non dominant-negative KCNJ2 gene mutations leading to Andersen-Tawil syndrome with an isolated cardiac phenotype.
Limberg MM; Zumhagen S; Netter MF; Coffey AJ; Grace A; Rogers J; Böckelmann D; Rinné S; Stallmeyer B; Decher N; Schulze-Bahr E
Basic Res Cardiol; 2013 May; 108(3):353. PubMed ID: 23644778
[TBL] [Abstract][Full Text] [Related]
11. Andersen's syndrome mutation effects on the structure and assembly of the cytoplasmic domains of Kir2.1.
Pegan S; Arrabit C; Slesinger PA; Choe S
Biochemistry; 2006 Jul; 45(28):8599-606. PubMed ID: 16834334
[TBL] [Abstract][Full Text] [Related]
12. Management and treatment of Andersen-Tawil syndrome (ATS).
Sansone V; Tawil R
Neurotherapeutics; 2007 Apr; 4(2):233-7. PubMed ID: 17395133
[TBL] [Abstract][Full Text] [Related]
13. A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome.
Doi T; Makiyama T; Morimoto T; Haruna Y; Tsuji K; Ohno S; Akao M; Takahashi Y; Kimura T; Horie M
Circ Cardiovasc Genet; 2011 Jun; 4(3):253-60. PubMed ID: 21493816
[TBL] [Abstract][Full Text] [Related]
14. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.
Plaster NM; Tawil R; Tristani-Firouzi M; Canún S; Bendahhou S; Tsunoda A; Donaldson MR; Iannaccone ST; Brunt E; Barohn R; Clark J; Deymeer F; George AL; Fish FA; Hahn A; Nitu A; Ozdemir C; Serdaroglu P; Subramony SH; Wolfe G; Fu YH; Ptácek LJ
Cell; 2001 May; 105(4):511-9. PubMed ID: 11371347
[TBL] [Abstract][Full Text] [Related]
15. Exaggerated Mg2+ inhibition of Kir2.1 as a consequence of reduced PIP2 sensitivity in Andersen syndrome.
Ballester LY; Vanoye CG; George AL
Channels (Austin); 2007; 1(3):209-17. PubMed ID: 18690034
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel, dominant negative KCNJ2 mutation associated with Andersen-Tawil syndrome.
Marrus SB; Cuculich PS; Wang W; Nerbonne JM
Channels (Austin); 2011; 5(6):500-9. PubMed ID: 22186697
[TBL] [Abstract][Full Text] [Related]
17. Kir 2.1 channelopathies: the Andersen-Tawil syndrome.
Tristani-Firouzi M; Etheridge SP
Pflugers Arch; 2010 Jul; 460(2):289-94. PubMed ID: 20306271
[TBL] [Abstract][Full Text] [Related]
18. Molecular and functional characterization of inwardly rectifying K
Huang X; Lee SH; Lu H; Sanders KM; Koh SD
J Physiol; 2018 Feb; 596(3):379-391. PubMed ID: 29205356
[TBL] [Abstract][Full Text] [Related]
19. Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen's syndrome.
Hosaka Y; Hanawa H; Washizuka T; Chinushi M; Yamashita F; Yoshida T; Komura S; Watanabe H; Aizawa Y
J Mol Cell Cardiol; 2003 Apr; 35(4):409-15. PubMed ID: 12689820
[TBL] [Abstract][Full Text] [Related]
20. Kir2.1 Interactome Mapping Uncovers PKP4 as a Modulator of the Kir2.1-Regulated Inward Rectifier Potassium Currents.
Park SS; Ponce-Balbuena D; Kuick R; Guerrero-Serna G; Yoon J; Mellacheruvu D; Conlon KP; Basrur V; Nesvizhskii AI; Jalife J; Rual JF
Mol Cell Proteomics; 2020 Sep; 19(9):1436-1449. PubMed ID: 32541000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
